110 research outputs found
A Polyclonal Immune Function Assay Allows Dose-Dependent Characterization of Immunosuppressive Drug Effects but Has Limited Clinical Utility for Predicting Infection on an Individual Basis
Dosage of immunosuppressive drugs after transplantation critically determines rejection and infection episodes. In this study, a global immune function assay was characterized among controls, dialysis-patients, and transplant-recipients to evaluate its utility for pharmacodynamic monitoring of immunosuppressive drugs and for predicting infections. Whole-blood samples were stimulated with anti-CD3/toll-like-receptor (TLR7/8)-agonist in the presence or absence of drugs and IFN-γ secretion was measured by ELISA. Additional stimulation-induced cytokines were characterized among T-, B-, and NK-cells using flow-cytometry. Cytokine-secretion was dominated by IFN-γ, and mainly observed in CD4, CD8, and NK-cells. Intra-assay variability was low (CV = 10.4 ± 6.2%), whereas variability over time was high, even in the absence of clinical events (CV = 65.0 ± 35.7%). Cyclosporine A, tacrolimus and steroids dose-dependently inhibited IFN-γ secretion, and reactivity was further reduced when calcineurin inhibitors were combined with steroids. Moreover, IFN-γ levels significantly differed between controls, dialysis-patients, and transplant-recipients, with lowest IFN-γ levels early after transplantation (p < 0.001). However, a single test had limited ability to predict infectious episodes. In conclusion, the assay may have potential for basic pharmacodynamic characterization of immunosuppressive drugs and their combinations, and for assessing loss of global immunocompetence after transplantation, but its application to guide drug-dosing and to predict infectious on an individual basis is limited
Novel human sex-typing strategies based on the autism candidate gene NLGN4X and its male-specific gametologue NLGN4Y
Background: Since the early days of PCR techniques, sex identification, “sex-typing,” of genomic DNA samples
has been a fundamental part of human forensic analysis but also in animal genetics aiming at strategic livestock
breeding. Most analyses are employing the AMELX/AMELY gene loci on the X and Y chromosomes present in most
mammals. We hypothesize that sex-typing in humans is also possible based on the genes NLGN4X and NLGN4Y,
which represent X and Y chromosome-specific copies of a common ancestral neuroligin-4 orthologue.
Methods: Genomic DNA was isolated from human blood and buccal cell samples (total n = 111) and submitted
to two different strategies: (a) a traditional two-primer PCR approach detecting an insertion/deletion (indel)
polymorphism immediately upstream of the translational start on exon 1 and (b) detection of a single nucleotide
polymorphism, SNP, on the translational stop carrying exon 7. The SNP detection was based on a quantitative PCR
approach (rhAMP genotyping) employing DNA/RNA hybrid oligonucleotides that were blocked and which could
only be activated upon perfect annealing to the target DNA sequence.
Results: All indel PCR-tested human DNA samples showed two bands for males representing X- and Y-specific
copies of NLGN4 and a single band for female samples, i.e., homozygosity of NLGN4X and absence of NLGN4Y, in
accordance with the self-reported sex of the donors. These results were in perfect agreement with the results of
the rhAMP-based SNP-detection method: all males were consequently positive for both alleles, representing either
SNP variant, and females were interpreted as homozygous regarding the SNP variant found in NLGN4X. Both
methods have shown reliable and consistent results that enabled us to infer the sex of donor DNA samples across
different ethnicities.
Conclusions: These results indicate that the detection of human NLGN4X/Y is a suitable alternative to previously
reported methods employing gene loci such as AMELX/Y. Furthermore, this is the first report applying successfully
the rhAMP-genotyping strategy as a means for SNP-based sex-typing, which consequently will be applicable to
other gene loci or different species as well
The transmembrane domain of the adenovirus E3/19K protein acts as an ER retention signal and contributes to intracellular sequestration of MHC class I molecules
The human adenovirus E3/19K-protein is a type-I transmembrane glycoprotein of the endoplasmic reticulum (ER) that abrogates cell-surface transport of MHC class-I (MHC-I) and MICA/B-molecules. Previous data suggested that E3/19K comprises two functional modules: a luminal domain for interaction with MHC-I and MICA/B-molecules, and a di-lysine motif in the cytoplasmic tail that confers retrieval from the Golgi back to the ER. This study was prompted by the unexpected phenotype of an E3/19K-molecule that was largely retained intracellularly despite having a mutated ER-retrieval motif. To identify additional structural determinants responsible for ER-localization, chimeric molecules were generated containing the luminal E3/19K-domain and the cytoplasmic and/or transmembrane domain (TMD) of the cell-surface protein MHC-I Kd. These were analysed for transport, cell-surface expression and impact on MHC-I/MICA/B down-regulation. Similar to the retrieval mutant, replacing the cytoplasmic tail of E3/19K allowed only limited transport of the chimera to the cell surface. Efficient cell-surface expression was only achieved by additionally replacing the TMD of E3/19K with that of MHC-I, suggesting that the E3/19K-TMD may confer static ER-retention. This was verified by ER-retention of an MHC-I Kd molecule with the TMD replaced by that of E3/19K. Thus, we have identified the E3/19K TMD as a novel functional element that mediates static ER-retention, thereby increasing its ER-concentration. Remarkably, the ER-retrieval signal alone without E3/19K-TMD did not mediate efficient HLA-down regulation, even in the context of infection. This suggests that the TMD is required together with the ER-retrieval function to ensure efficient ER-localization and transport inhibition of MHC-I and MIC-A/B-molecules
Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients
Background: Graft survival in transplant recipients depends on pharmacokinetics and on individual susceptibility
towards immunosuppressive drugs. Nevertheless, pharmacodynamic changes in T-cell functionality in response to
drugs and in relation to pharmacokinetics are poorly characterized. We therefore investigated the immunosuppressive
effect of calcineurin inhibitors and steroids on general T-cell functionality after polyclonal stimulation of whole blood
samples.
Methods: General T-cell functionality in the absence or presence of immunosuppressive drugs was determined in vitro
directly from whole blood based on cytokine induction after stimulation with the polyclonal stimulus Staphylococcus
aureus enterotoxin B. In addition, diurnal changes in leukocyte and lymphocyte subsets, and on T-cell function after
intake of immunosuppressive drugs were analyzed in 19 patients during one day and compared to respective kinetics
in six immunocompetent controls. Statistical analysis was performed using non-parametric and parametric tests.
Results: Susceptibility towards calcineurin inhibitors showed interindividual differences. When combined with steroids,
tacrolimus led to more pronounced increase in the inhibitory activity as compared to cyclosporine A. While circadian
alterations in leukocyte subpopulations and T-cell function in controls were related to endogenous cortisol levels, T-cell
functionality in transplant recipients decreased after intake of the morning medication, which was more pronounced in
patients with higher drug-dosages. Interestingly, calcineurin inhibitors differentially affected circadian rhythm of T-cell
function, as patients on cyclosporine A showed a biphasic decrease in T-cell reactivity after drug-intake in the morning
and evening, whereas T-cell reactivity in patients on tacrolimus remained rather stable.
Conclusions: The whole blood assay allows assessment of the inhibitory activity of immunosuppressive drugs in
clinically relevant concentrations. Circadian alterations in T-cell function are determined by dose and type of
immunosuppressive drugs and show distinct differences between cyclosporine A and tacrolimus. In future these
findings may have practical implications to estimate the net immunosuppressive effect of a given drug-regimen
that daily acts in an individual patient, and may contribute to individualize immunosuppressio
Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients
Background: Graft survival in transplant recipients depends on pharmacokinetics and on individual susceptibility
towards immunosuppressive drugs. Nevertheless, pharmacodynamic changes in T-cell functionality in response to
drugs and in relation to pharmacokinetics are poorly characterized. We therefore investigated the immunosuppressive
effect of calcineurin inhibitors and steroids on general T-cell functionality after polyclonal stimulation of whole blood
samples.
Methods: General T-cell functionality in the absence or presence of immunosuppressive drugs was determined in vitro
directly from whole blood based on cytokine induction after stimulation with the polyclonal stimulus Staphylococcus
aureus enterotoxin B. In addition, diurnal changes in leukocyte and lymphocyte subsets, and on T-cell function after
intake of immunosuppressive drugs were analyzed in 19 patients during one day and compared to respective kinetics
in six immunocompetent controls. Statistical analysis was performed using non-parametric and parametric tests.
Results: Susceptibility towards calcineurin inhibitors showed interindividual differences. When combined with steroids,
tacrolimus led to more pronounced increase in the inhibitory activity as compared to cyclosporine A. While circadian
alterations in leukocyte subpopulations and T-cell function in controls were related to endogenous cortisol levels, T-cell
functionality in transplant recipients decreased after intake of the morning medication, which was more pronounced in
patients with higher drug-dosages. Interestingly, calcineurin inhibitors differentially affected circadian rhythm of T-cell
function, as patients on cyclosporine A showed a biphasic decrease in T-cell reactivity after drug-intake in the morning
and evening, whereas T-cell reactivity in patients on tacrolimus remained rather stable.
Conclusions: The whole blood assay allows assessment of the inhibitory activity of immunosuppressive drugs in
clinically relevant concentrations. Circadian alterations in T-cell function are determined by dose and type of
immunosuppressive drugs and show distinct differences between cyclosporine A and tacrolimus. In future these
findings may have practical implications to estimate the net immunosuppressive effect of a given drug-regimen
that daily acts in an individual patient, and may contribute to individualize immunosuppressio
Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients
Knowledge on the immunogenicity of vector-based and mRNA-vaccines in solid organ
transplant recipients is limited. Therefore, SARS-CoV-2–specific T cells and antibodies were analyzed in 40 transplant recipients and 70 controls after homologous or
heterologous vaccine-regimens. Plasmablasts and SARS-CoV-2–specific CD4 and
CD8 T cells were quantified using flow cytometry. Specific antibodies were analyzed
by ELISA and neutralization assay. The two vaccine types differed after the first vaccination, as IgG and neutralizing activity were more pronounced after mRNA priming
(p = .0001 each), whereas CD4 and CD8 T cell levels were higher after vector priming
(p = .009; p = .0001). All regimens were well tolerated, and SARS-CoV-2–specific antibodies and/or T cells after second vaccination were induced in 100% of controls and
70.6% of transplant recipients. Although antibody and T cell levels were lower in patients, heterologous vaccination led to the most pronounced induction of antibodies
and CD4 T cells. Plasmablast numbers were significantly higher in controls and correlated with SARS-CoV-2–specific IgG- and T cell levels. While antibodies were only
detected in 35.3% of patients, cellular immunity was more frequently found (64.7%)
indicating that assessment of antibodies is insufficient to identify COVID-19-vaccine
responders. In conclusion, heterologous vaccination seems promising in transplant recipients, and combined analysis of humoral and cellular immunity improves the identification of responders among immunocompromised individuals
Transient Positive SARS-CoV-2 PCR without Induction of Systemic Immune Responses
SARS-CoV-2 testing is dominated by PCR to guide treatment and individual as well as
public health preventive measures. Among 1700 football (soccer) players and staff of the German
Bundesliga and Bundesliga 2 who were regularly tested by PCR twice weekly, 98 individuals had a
positive PCR (May 2020 to mid-January 2021). A subset of these were retested shortly after the initial
positive result. Among those, 11 subjects were identified who only had a transient single positive PCR
of low viral load. All individuals were asymptomatic and none developed long COVID. We tested
SARS-CoV-2 IgG and IgA as well as SARS-CoV-2 specific CD4 und CD8 positive T cells, and showed
that only one out of 11 individuals developed SARS-CoV-2 specific cellular and humoral immunity
after the positive PCR, whereas a specific immunity was undetectable in all other individuals. Thus,
a single positive PCR might indicate that transient colonization of the upper respiratory tract with
SARS-CoV-2 may occur without systemic induction of specific adaptive immunity. Together with test
artifacts as another potential reason for a transiently positive test, this finding may favor cautious
interpretation of positive PCR results or retesting before initiating intervening treatment or infection
control measures in some cases
Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients
<p>Abstract</p> <p>Background</p> <p>Cytomegalovirus (CMV) seronegative recipients (R-) of kidney transplants (KT) from seropositive donors (D+) are at higher risk for CMV replication and ganciclovir(GCV)-resistance than CMV R(+). We hypothesized that low CMV-specific T-cell responses are associated with increased risk of CMV replication in R(+)-patients with D(+) or D(-) donors.</p> <p>Methods</p> <p>We prospectively evaluated 73 consecutive KT-patients [48 R(+), 25 D(+)R(-)] undergoing routine testing for CMV replication as part of a preemptive strategy. We compared CMV-specific interferon-Îł (IFN-Îł) responses of CD4+CD3+ lymphocytes in peripheral blood mononuclear cells (PBMC) using three different antigen preparation (CMV-lysate, pp72- and pp65-overlapping peptide pools) using intracellular cytokine staining and flow cytometry.</p> <p>Results</p> <p>Median CD4+ and CD8+T-cell responses to CMV-lysate, pp72- and pp65-overlapping peptide pools were lower in D(+)R(-) than in R(+)patients or in non-immunosuppressed donors. Comparing subpopulations we found that CMV-lysate favored CD4+- over CD8+-responses, whereas the reverse was observed for pp72, while pp65-CD4+- and -CD8+-responses were similar. Concurrent CMV replication in R(+)-patients was associated with significantly lower T-cell responses (pp65 median CD4+ 0.00% vs. 0.03%, p = 0.001; CD8+ 0.01% vs. 0.03%; p = 0.033). Receiver operated curve analysis associated CMV-pp65 CD4+ responses of > 0.03% in R(+)-patients with absence of concurrent (p = 0.003) and future CMV replication in the following 8 weeks (p = 0.036). GCV-resistant CMV replication occurred in 3 R(+)-patients (6.3%) with pp65- CD4+ frequencies < 0.03% (p = 0.041).</p> <p>Conclusion</p> <p>The data suggest that pp65-specific CD4+ T-cells might be useful to identify R(+)-patients at increased risk of CMV replication. Provided further corroborating evidence, CMV-pp65 CD4+ responses above 0.03% in PBMCs of KT patients under stable immunosuppression are associated with lower risk of concurrent and future CMV replication during the following 8 weeks.</p
Numerical modelling of label-structured cell population growth using CFSE distribution data
<p>Abstract</p> <p>Background</p> <p>The flow cytometry analysis of CFSE-labelled cells is currently one of the most informative experimental techniques for studying cell proliferation in immunology. The quantitative interpretation and understanding of such heterogenous cell population data requires the development of distributed parameter mathematical models and computational techniques for data assimilation.</p> <p>Methods and Results</p> <p>The mathematical modelling of label-structured cell population dynamics leads to a hyperbolic partial differential equation in one space variable. The model contains fundamental parameters of cell turnover and label dilution that need to be estimated from the flow cytometry data on the kinetics of the CFSE label distribution. To this end a maximum likelihood approach is used. The Lax-Wendroff method is used to solve the corresponding initial-boundary value problem for the model equation. By fitting two original experimental data sets with the model we show its biological consistency and potential for quantitative characterization of the cell division and death rates, treated as continuous functions of the CFSE expression level.</p> <p>Conclusion</p> <p>Once the initial distribution of the proliferating cell population with respect to the CFSE intensity is given, the distributed parameter modelling allows one to work directly with the histograms of the CFSE fluorescence without the need to specify the marker ranges. The label-structured model and the elaborated computational approach establish a quantitative basis for more informative interpretation of the flow cytometry CFSE systems.</p
Whole-Blood Flow-Cytometric Analysis of Antigen-Specific CD4 T-Cell Cytokine Profiles Distinguishes Active Tuberculosis from Non-Active States
T-cell based IFN-γ release assays do not permit distinction of active tuberculosis (TB) from successfully treated disease or latent M. tuberculosis infection. We postulated that IFN-γ and IL-2 cytokine profiles of antigen-specific T cells measured by flow-cytometry ex vivo might correlate with TB disease activity in vivo. Tuberculin (PPD), ESAT-6 and CFP-10 were used as stimuli to determine antigen-specific cytokine profiles in CD4 T cells from 24 patients with active TB and 28 patients with successfully treated TB using flow-cytometry. Moreover, 25 individuals with immunity consistent with latent M. tuberculosis infection and BCG-vaccination, respectively, were recruited. Although the frequency of cytokine secreting PPD reactive CD4 T cells was higher in patients with active TB compared to patients with treated TB (median 0.81% vs. 0.39% of CD4 T cells, p = 0.02), the overlap in frequencies precluded distinction between the groups on an individual basis. When assessing cytokine profiles, PPD specific CD4 T cells secreting both IFN-γ and IL-2 predominated in treated TB, latent infection and BCG-vaccination, whilst in active TB the cytokine profile was shifted towards cells secreting IFN-γ only (p<0.0001). Cytokine profiles of ESAT-6 or CFP-10 reactive CD4 T cells did not differ between the groups. Receiver operator characteristics (ROC) analysis revealed that frequencies of PPD specific IFN-γ/IL-2 dual-positive T cells below 56% were an accurate marker for active TB (specificity 100%, sensitivity 70%) enabling effective discrimination from non-active states. In conclusion, a frequency lower than 56% IFN-γ/IL-2 dual positive PPD-specific circulating CD4 T-cells is strongly indicative of active TB
- …